Home/Pipeline/STEP Investment Program

STEP Investment Program

Critical Medicines Production

Development/ConstructionActive

Key Facts

Indication
Critical Medicines Production
Phase
Development/Construction
Status
Active
Company

About Antibiotice

Antibiotice is a well-established, revenue-generating Romanian generic drug manufacturer with a significant international footprint. The company is executing a major 75 million euro investment to develop an R&D and production center for critical medicines, signaling a strategic expansion. It maintains strong regulatory standing with multiple FDA approvals and eight GMP-certified lines, positioning it as a reliable partner in the global generic pharmaceuticals market.

View full company profile